baber/WOPTO huggingface dataset:
Patent DE-69705346-D1 (DE)
Inventor: HABERKORN JEAN-PAUL
IPC: A01D34/63
Filed: 1997-04-03
Granted: 2001-08-02
Abstract: The harvesting reaping implement has a cutter (4) with a working position and a spaced position above the soil. A coupling (2) connects the implement to the towing tractor. A carrying beam (3) is connected to the hitch via a first pivot (10) and to the cutter by a second pivot. A handling actuator (5) moves the implement between work and retracted positions. A handling boom (25) connects to the cutter and has a lever (27) connected to the cutter via a third pivot (29) and a screw (56) to hold it in the retracted position. The boom has a second lever (35) connected to a part of the beam via an articulation (36) and to the first lever by a further articulation (37).
Patent DE-69709329-D1 (DE)
Inventor: BELFORTE PIERO
IPC: G01R31/28
Filed: 1997-04-01
Granted: 2002-01-31
Abstract: An electronic telecommunications module has circuit components and conductors forming a telecommunications circuit having insertion points at which signals can be applied for test purposes and monitoring points from which responses can be tapped. The insertion and monitoring probes are mounted on the module and are connected to the respective points by shielded microcoaxial cables and the probes are connected by shield and microcoaxial cables on the connectors to allow interfacing between the particular module and the testing and diagnostic system.
Patent DE-69713351-D1 (DE)
Inventor: MOGENSEN BENT
IPC: A61C13/34
Filed: 1997-09-10
Granted: 2002-07-18
Abstract: PCT No. PCT/DK97/00382 Sec. 371 Date Mar. 9, 1999 Sec. 102(e) Date Mar. 9, 1999 PCT Filed Sep. 10, 1997 PCT Pub. No. WO98/10709 PCT Pub. Date Mar. 19, 1998A mould for casting a base for a dental model when reconstructing teeth for dentures or parts thereof and including a base plate along the edge of which a mould cavity is placed, the mould cavity including a bottom with fixating structures for the dental model or parts thereof, and walls provided with ribs extending from the bottom, the mould cavity having the shape of at least a part of a jaw. With a view to creating a stable mould, in which the model cast on the base may be remounted and positioned without rocking, the mould is designed in such a way that the fixation structures are at least substantially cylindrical pins which can be inserted in corresponding holes in the bottom of the mould cavity and which each include a portion suited for being cast in the base of the dental model.
Patent DE-69715865-D1 (DE)
Inventor: KOZLOWSKI A
IPC: C07D317/62
Filed: 1997-06-26
Granted: 2002-10-31
Abstract: Di-N-substituted piperazine or 1,4-di-substituted piperidine compounds in accordance with formula (I) (including all isomers, salts, esters, and solvates), wherein Q, n, R, R<1>, R<2>, R<3>, R<4>, R<21>, R<27>, R<28>, X, and Z are as defined herein are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed. Also disclosed are synergistic combinations with acetylcholinesterase inhibitors of compounds capable of enhancing acetylcholine release and having the above formula.
Patent DE-69725623-D1 (DE)
Inventor: MOONEY BRIAN FRANCIS
IPC: B01F3/08
Filed: 1997-02-21
Granted: 2003-11-20
Abstract: PCT No. PCT/IE97/00011 Sec. 371 Date Aug. 19, 1998 Sec. 102(e) Date Aug. 19, 1998 PCT Filed Feb. 21, 1997 PCT Pub. No. WO97/30930 PCT Pub. Date Aug. 28, 1997An apparatus for adding an additive, such as a marker, to a base fluid, such as oil, includes a blender having a receptacle or diffusion chamber in which mixing of the additive and the base fluid occurs. The additive is injected in discrete amounts. Resistances to fluid flow in the receptacle or chamber cause fluid flow to occur at different rates in order to reduce the slugging effect caused by additive injection in discrete amounts.
Patent DE-69725860-D1 (DE)
Inventor: CEDERBERG CHRISTER
IPC: A61K31/4439
Filed: 1997-06-18
Granted: 2003-12-04
Abstract: A new administration regimen giving an extended plasma concentration profile of a H+, K+-ATPase inhibitor. The extended plasma profile is received by two or more consecutive administrations of a unit dose of a H+, K+-ATPase with 0.5-4 hours interval or by a pharmaceutical composition with extended release, which may be administered once daily.
Patent DE-69726438-D1 (DE)
Inventor: HANAFIN JOSEPH W
IPC: C08K5/523
Filed: 1997-09-23
Granted: 2004-01-08
Abstract: A low density, epoxy-based intumescent fire resistive coating, having a density below about 1.10 grams/cc, and most preferably below about 1.0 grams/cc, and a method for forming the same, are disclosed. This method includes the steps of forming an epoxy-based intumescent mastic, having minute particles of amorphous silica dispersed therein. The mastic is then sprayed in droplets on at least one surface of a substrate to form a low density mastic coating on the surface. The low density mastic coating then cures to form a low density, intumescent fire resistive coating. Preferably, the method of invention further includes the step of dispersing at least one type of gas within the mastic, or within at least one part of the mastic to further reduce the density of the cured intumescent coating.
Patent DE-69729176-D1 (DE)
Inventor: EIDEN C
IPC: H01J49/42
Filed: 1997-01-03
Granted: 2004-06-24
Abstract: The present invention relates generally to a method for producing an ion beam having an increased proportion of analyte ions compared to carrier gas ions. More specifically, the method has steps resulting in selectively neutralizing carrier gas ions. Apparatus for providing an ion beam having an increased proportion of analyte ions compared to carrier gas ions, comprising: (a) an ion source for providing a beam comprising a mixture of carrier gas ions and analyte ions, (b) means for exposing said mixture to a reagent gas comprising hydrogen gas so that charge is selectively transferred from the carrier gas ions to the hydrogen gas, thereby neutralizing the carrier gas ions and forming charged hydrogen gas. <IMAGE>
Patent DE-69733731-D1 (DE)
Inventor: PETERSON ALEX A
IPC: A61M25/00
Filed: 1997-05-07
Granted: 2005-08-25
Abstract: An intravascular catheter (10,110) having an elongated tubular body with a proximal portion, a distal portion and a lumen extending therebetween. The tubular body is formed with: (a) a first layer (21,128) of polytetrafluoroethylene; (b) a reinforcing element (22,130) at least partially surrounding the inner layer; and (c) a second layer (23,132) comprising a blend of polyetherester elastomer and polybutylene terephthalate at least partially covering the second layer (23,132). <IMAGE>
Patent DE-69736126-D1 (DE)
Inventor: TARTAGLIA JAMES
IPC: A61K39/12
Filed: 1997-11-07
Granted: 2006-07-27
Abstract: Recombinants containing and expressing lentivirus, retrovirus or immunodeficiency virus DNA and methods for making and using the same are disclosed and claimed. In an exemplified embodiment, attenuated recombinant viruses containing DNA encoding a feline immunodeficiency virus epitope such as an antigen, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinants can be NYVAC or ALVAC recombinants. The DNA can encode at least one of: Env, Gag, Pol, or combinations thereof such as Gag and Pol or protease or Env, Gag and Pol or protease. The recombinants and gene products therefrom and antibodies generated by them have several preventive, therapeutic and diagnostic uses. DNA from the recombinants are useful as probes or, for generating PCR primers or for immunization. The immunogenicity and protective efficacy of immunization protocols involving ALVAC-FIV and priming with a recombinant canarypox virus ALVAC-FIV vaccine followed by a booster immunization with inactivated FIV-infected celled vaccine (ICV) was evaluated against FIV challenge in cats and the protocol was shown to effectively induce FIV-specific protective immune responses. Further, it was found that immunized cats were fully protected from an initial challenge with a slightly heterologous FIV strain (50CID<SUB>50</SUB>) and were partially protected from a second challenge with a distinctly heterologous FIV strain (75CID<SUB>50</SUB>) given eight months after the initial challenge without any intervening booster.
Patent DE-69739037-D1 (DE)
Inventor: REED BARRY LEONARD
IPC: A61K31/704
Filed: 1997-02-19
Granted: 2008-11-20
Abstract: A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer, characterised in that the dermal penetration enhancer is a safe skin-tolerant ester sunscreen. A non-occlusive, percutaneous or transdermal drug delivery system which comprises: (i) an effective amount of at least one physiologically active agent or prodrug thereof; (ii) at least one non-volatile dermal penetration enhancer, and (iii) at least one volatile liquid; characterized in that the dermal penetration enhancer is adapted to transport the physiologically active agent across a dermal surface or mucosal membrane of an animal, including a human, when the volatile liquid evaporates, to form a reservoir or depot of a mixture comprising the penetration enhancer and the physiologically active agent or prodrug within said surface or membrane; and the dermal penetration enhancer is of low toxicity to, and is tolerated by, the dermal surface or mucosal membrane of the animal.
Patent DE-69808938-D1 (DE)
Inventor: RAO SESHAGIRI
IPC: A61K31/522
Filed: 1998-09-02
Granted: 2002-11-28
Abstract: A pharmaceutical formulation may be prepared by a method comprising providing the active ingredient in solution in a pharmacologically-acceptable base and mixing the resulting solution with a pharmacologically-acceptable acid in an amount such that the formulation attains a pH in the range of from about 3.5 to about 8.5 to thereby precipitate out the active ingredients, a viscosity-enhancing agent having been incorporated in the formulation prior to or during the mixing with acid. The formulation is suitable for administration of a pharmacologically active ingredient which is sparingly soluble in water at a pH acceptable for administration, for example to the eye of the patient.
Patent DE-69810065-D1 (DE)
Inventor: DECLERCQ DRIES
IPC: C23G1/02
Filed: 1998-01-12
Granted: 2003-01-23
Abstract: PCT No. PCT/EP98/00158 Sec. 371 Date Nov. 5, 1998 Sec. 102(e) Date Nov. 5, 1998 PCT Filed Jan. 12, 1998 PCT Pub. No. WO98/31491 PCT Pub. Date Jul. 23, 1998The invention relates to a metal fiber agglomerate comprising fibers with an equivalent diameter of between 1  mu m and 30  mu m and with a length of between 1 mm and 20 mm, with the feature that the core of the agglomerate contains at least one bundle of fibers oriented substantially parallel to one another, while the casing consists of a network of randomly oriented fibers. The invention also relates to a process for the manufacture of these metal fiber agglomerates, characterized by a succession of steps in which the agglomerate is subjected to a continuous tumbling movement.
Patent DE-69811867-D1 (DE)
Inventor: KELLY ALFRED
IPC: A61P29/00
Filed: 1998-03-03
Granted: 2003-04-10
Abstract: A method treating or preventing inflammatory and immune cell-mediated diseases by the administration of certain novel and known small molecules. Exemplary of the novel compounds are those of structural formulas (a), (b), (c), (d), (e) and (f).
Patent DE-69811940-D1 (DE)
Inventor: KOTWICA ROLAND
IPC: C07C7/04
Filed: 1998-11-23
Granted: 2003-04-10
Abstract: For the purification of the norbornene obtained by the reaction of dicyclopentadiene or cyclopentadiene and ethylene, the crude reaction mixture containing light impurities having boiling temperatures lower than that of norbornene; medium-heavy impurities having the boiling temperatures between that of norbornene and that of ethylnorbornene; and heavy impurities containing ethylnorbornene and compounds boiling higher than ethylnorbornene, boiling temperatures greater than that ethylnorbornene, a first distillation of the crude reaction mixture is carried out in a tailing column (C1), removing a portion of the heavy impurities and a portion of the medium-heavy impurities; then a second distillation of the crude mixture, thus tailed, is carried out in a topping column (C2), removing the light impurities; and a third distillation of the mixture, thus topped, is subsequently carried out in a tailing column (C3), removing the remainder of the heavy and medium-heavy impurities.
Patent DE-69817598-D1 (DE)
Inventor: HARTNAGEL PHILIP
IPC: B60H1/00
Filed: 1998-10-30
Granted: 2003-10-02
Abstract: A tube assembly for an auxiliary heating and air conditioning system includes an inner tube extending longitudinally, an outer tube extending longitudinally and disposed over the inner tube, the outer tube including a plurality of ribs for locating the inner tube approximately concentric to the outer tube, at least one connector tube, and at least one connector interconnecting the at least one connector tube and the outer tube to allow fluid flow between the inner tube and the outer tube.
Patent DE-69817753-D1 (DE)
Inventor: MCKENDRICK FRANCIS RYAN
IPC: E02B3/04
Filed: 1998-09-10
Granted: 2003-10-09
Abstract: A geosynthetic clay liner (GCL) is provided that includes a layer of water-swellable smectite clay (12), e.g., sodium montmorillonite disposed between a carrier sheet and a cover sheet. An inner sheet (13), disposed against the surface to be protected against water penetration - either the carrier sheet or the cover sheet - is made of material having a more open structure that allows hydrated bentonite to migrate through it. The other, e.g., outer sheet (11), includes a more closed structure and, therefore, precludes substantial bentonite migration through it. The GCL can be held together in any manner known, e.g., by adhesively affixing the clay to the sheet material layers, or by needle-punching or stitching the sheet materials together surrounding the intermediate clay layer. <IMAGE>
Patent DE-69824661-D1 (DE)
Inventor: COUILLARD DANIEL
IPC: B01D45/18
Filed: 1998-04-23
Granted: 2004-07-29
Abstract: Grease biodegrading bacteria consortia are continuously mixed with a flow of air loaded with grease which is sent through an exhaust hood. Preferably, the exhaust hood includes a filter device which comprises a narrowing passageway which is located immediately below a baffle filter thereby regularly distributing the air flow through the entire area of the baffle filter. The hood is constructed to cause a swirling motion to the air flow. <IMAGE>
Patent DE-69825445-D1 (DE)
Inventor: HODGES ALASTAIR
IPC: B01J49/30
Filed: 1998-05-08
Granted: 2004-09-09
Abstract: A method of treating an ion exchange material, the method including: (a) positioning at least two regions of ion exchange material between an anode and cathode electrode, wherein at least a portion of the two regions being in electrical contact and being separated by a non-ion specific permeable interface; (b) supplying water to the at least two regions; (c) applying an electric potential between the electrodes thereby causing generation of hydrogen ions at the anode and hydroxide ions at the cathode, which ions are caused to move through each region towards the oppositely-charged electrode and thereby displacing at least a portion of any anions or cations associated with the ion exchange material in each region such that the displaced anions and cations are also caused to move through the regions towards the oppositely charged electrode; and (d) removing at least some of the cations and/or anions formed during step (c) which reach the interface.
Patent DE-69826644-D1 (DE)
Inventor: KAMM MICHAEL ALBERT
IPC: A61K9/00
Filed: 1998-02-23
Granted: 2004-11-04
Abstract: Nifedipine, optionally in combination with bethanechol, is administered locally to the anus for the treatment of benign anal disorders, in particular anal fissures and haemorrhoids. The agents induce a reduction in the mean and resting pressure, thereby assisting in the healing of anal fissures and haemorrhoids. Optionally, the active agents may be co-administered with a steroid, such as hydrocortisone.
Patent DE-69834570-D1 (DE)
Inventor: VEZINA LOUIS
IPC: C12N15/13
Filed: 1998-11-10
Granted: 2006-06-22
Abstract: <P>PROBLEM TO BE SOLVED: To provide a transgenic plant for producing a transgenic protein stably.  <P>SOLUTION: A method for stably producing an extractable protein includes the following processes: (a) a process of selecting an alfalfa gene type showing a negligible proteinase activity for at least 3 hrs in an extract; (b) a process of transforming at least one alfalfa plant having the gene type selected in the process (a) with a vector containing a gene encoding the protein to produce at least one transformed alfalfa plant; (c) a process of confirming the presence of the gene in the above at least one transformed type alfalfa plant; (d) a process of growing the at least one transformed type alfalfa plant to produce such the protein; and (e) a process of extracting the protein from the plant.  <P>COPYRIGHT: (C)2009,JPO&INPIT
Patent DE-69838249-D1 (DE)
Inventor: ASHKENAZI AVI J
IPC: C12N5/10
Filed: 1998-05-14
Granted: 2007-09-27
Abstract: Novel polypeptides, designated Apo-2, which are capable of modulating apoptosis are provided. Compositions including Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 are also provided.
Patent DE-69900847-D1 (DE)
Inventor: GREENBERG S
IPC: C12Q1/48
Filed: 1999-04-16
Granted: 2002-03-14
Abstract: The invention provides methods, therapeutics and kits for treating and preventing diseases or conditions associated with excessive lipolysis, in particular TNF- alpha  induced lipolysis, and/or excessive free fatty acid levels. Exemplary conditions include insulin-resistance, diabetes, in particular NIDDM, obesity, glucose intolerance, hyperinsulinemia, polycystic ovary syndrome, and coronary artery disease. In a preferred embodiment, the method includes administering to a subject in need a pharmaceutically effective amount of an inhibitor of the JNK signal transduction pathway and/or an inhibitor of the MAPK/ERK signal transduction pathway and/or a stimulator of the p38 signal transduction pathway.
Patent DE-69903041-D1 (DE)
Inventor: EMILSSON FRED
IPC: B61H1/00
Filed: 1999-07-12
Granted: 2002-10-24
Abstract: A rail vehicle bogie comprises a tranverse bolster (1), two side frames (2) and two wheel sets (3) with wheels (4). A bogie brake comprises between the two wheel sets two tranverse brake beams (5) arranged to be pressed apart by brake actuators (11) for braking engagement by brake blocks (6) at the ends of the brake beams with the treads of the wheels. According to the invention the brake actuators (11) are arranged in the brake beams (5) close to the wheels (4) and are integrated in the beams, which otherwise are built-up of plate profiles (15).
Patent DE-69915105-D1 (DE)
Inventor: FORD H
IPC: E06B7/28
Filed: 1999-12-02
Granted: 2004-04-01
Abstract: A protection device is for restricting an object from sliding along an edge formed by a pair of surfaces of a structure. The protection device includes an obstruction fixture having a mounting surface and a body projecting away from the mounting surface, and a fastener securing the mounting surface to at least one of the surfaces of the structure. The obstruction fixture is positioned on the structure with the body positioned sufficiently close to the edge such that the object sliding along the edge will contact the body.
Patent DE-69917294-D1 (DE)
Inventor: SRIVASTAVA ARADHANA
IPC: C12N1/19
Filed: 1999-09-08
Granted: 2004-06-17
Abstract: The invention describes industrial fermentation of a Saccharomyces yeast species for production of a heterologous product encoded by a plasmid or DNA contained in said Saccharomyces yeast species with method utilizes the substrate more efficiently and without fermentative metabolism resulting in formation of ethanol and other unwanted primary products of fermentative activity whereby high yields of the heterologous product are obtained. The Saccharomyces yeast species is preferably a Crabtree negative Saccharomyces species in particular Saccharomyces kluyveri.
Patent DE-69918563-D1 (DE)
Inventor: YAMAKA MASATAKA
IPC: A61B5/01
Filed: 1999-09-29
Granted: 2004-08-12
Abstract: A probe cover detaching mechanism for detaching a probe cover mounted to abut against a probe that is to be inserted into the earhole from the probe includes an operating member to which is applied an operating force for detaching the probe cover from the probe, a push member pushing the probe cover toward the distal end of the probe upon receipt of the operating force applied to the operating member and transmitted from the operating member, and a mechanism joining the operating member with the push member and changing the direction of the operating force applied to the operating member by substantially 90 DEG  so as to transmit the operating force to the push member. <IMAGE>
Patent DE-69920954-D1 (DE)
Inventor: CASSISA ERIC
IPC: C08F210/16
Filed: 1999-11-26
Granted: 2004-11-11
Abstract: The present invention relates to a process for controlling a continuous fluidised bed reactor (co-)polymerisation process which comprises  1. withdrawing from the reactor a hot recycle stream comprising a principal monomer and at least another unreacted reactant, 2. cooling part or all of said recycle stream withdrawn from said reactor, and 3. recycling part or all of said cooled recycle stream comprising the principal monomer and the unreacted reactant(s) through the polymerisation zone in said reactor in the presence of a polymerisation catalyst under reactive conditions,  characterised in that the said controlling process consists in maintaining at least one of the reactant gradients (Gri) within a range of values which would otherwise cause sheeting or unstable operations.
Patent DE-69922555-D1 (DE)
Inventor: TULLOCH JOHN S
IPC: G01R31/58
Filed: 1999-08-03
Granted: 2005-01-13
Abstract: A method for inspecting a wire, a cable or a bundle of wires to locate those parts of said wires or cables having damaged insulation before failure of the wire or cable occurs, the method comprising the steps of: passing a current through said wire or cable, applying a fluid having electrolytic properties to said wire, cable or bundle of wires, using an infra-red thermal imaging system to detect and display the intensity of heat emanating from said wire or cable following addition of the fluid.
Patent DE-69924379-D1 (DE)
Inventor: TRACEY J
IPC: C07D213/79
Filed: 1999-07-16
Granted: 2005-04-28
Abstract: There is disclosed a genus of compounds and pharmaceutical compositions that are protective for mitigating damage associated with tissue ischemia, particularly stroke (CNS ischemia), and ischemia of the myocardium. The present invention further provides a method for treating tissue damage caused by ischemia. Lastly, the present invention provides a method for treating tissue damage caused by providing a compound that inhibits the cytotoxic activity of 3-aminopropanal.
Patent DE-69926373-D1 (DE)
Inventor: GIBSON CHARLES
IPC: C08F/
Filed: 1999-06-04
Granted: 2005-09-01
Abstract: A polymerisation process for the preparation of vinylic polymers from the corresponding vinylic monomers which process comprises the step of reacting a vinylic monomer in the presence of a catalyst system comprising a) a metal complex of general formula (I) where A is selected from the group consisting of nickel, iron, cobalt, chromium, manganese, titanium, zirconium, vanadium and the rare earth metals; L<1>, L<2>, L<3 >and L<4 >are ligands and b) a Lewis acid of general formula (II) wherein at least one of W, Y or Z is capable of forming a co-ordination bond with A and the others of W, Y and Z are bulky groups; D is selected from the group consisting of aluminium, magnesium, zinc and boron.